Waist-Hip Ratio and Your Genetics
WHR Additive Genetics: ANGPTL4, TBX15, and Lipid Loci | ExomeDNA
By the ExomeDNA Research Team | Last reviewed May 2026
Research base: Robust.
What is waist-to-hip ratio adjusted for BMI?
Waist-to-hip ratio (WHR) measures how fat is distributed between the waist and hips, with BMI adjustment isolating distribution from overall body size. The additive genetic model, used in this analysis, assumes that each additional copy of a risk allele contributes a fixed, independent increment to WHR. This statistical framework maximizes power for detecting common variants whose effects accumulate across allele copies—a well-suited approach for continuous distribution traits shaped by many small genetic contributions.
Where fat accumulates around the waist versus the hips is partly heritable and partly distinct from overall adiposity. Central fat accumulation—reflected in elevated WHR—is associated with elevated susceptibility for cardiometabolic conditions. Identifying protein-coding variants contributing to this trait provides directional evidence about the molecular mechanisms involved.
The genetics behind fat distribution
The strongest additive-model signals for BMI-adjusted WHR include variants near FGFR4, TBX15, ANGPTL4, ACVR1C, RREB1, WSCD2, RAPGEF3, PLCE1, RSPO3, and PDE5A. This gene set emphasizes lipid metabolism and lipolysis regulation alongside developmental patterning of fat depot identity.
FGFR4 encodes a fibroblast growth factor receptor involved in hepatic lipid metabolism and adipose regulation—consistently one of the top signals for WHR across multiple study designs. ANGPTL4 encodes angiopoietin-like protein 4, a secreted inhibitor of lipoprotein lipase (LPL). LPL controls the release of fatty acids from circulating lipoproteins for uptake into tissues; ANGPTL4 limits this activity, particularly in oxidative tissues. Variants near ANGPTL4 may alter how efficiently fat is deposited in or mobilized from specific tissue compartments, contributing to where fat preferentially accumulates.
TBX15 is a T-box transcription factor that marks distinct adipocyte populations in different body regions. It encodes positional identity for fat cells—whether adipocytes in a given depot develop as abdominal or gluteal in character. Genetic variation near TBX15 influences developmental patterning of fat depot identity rather than metabolic regulation per se. The gene is expressed at high levels in gluteal fat relative to abdominal fat, and its variants associate with WHR in ways consistent with a role in determining the relative growth capacity of peripheral versus central depots.
Whole-exome sequencing identified protein-coding variants near ANGPTL4, ACVR1C, and related lipid homeostasis genes as contributors to central fat distribution and WHR, providing functional hypotheses for causal mechanisms (Justice et al., 2019).
ACVR1C encodes a type I TGF-beta family receptor that binds activin C and activin E. Activin signaling through ACVR1C modulates adipogenesis and hepatic fat metabolism. Loss-of-function variants in ACVR1C have been associated with reduced central adiposity and improved metabolic markers in large-scale studies. RAPGEF3 encodes a cAMP-regulated exchange factor (EPAC1) with roles in lipolysis signaling; it may influence the efficiency with which fat cells release stored lipids in response to hormonal signals. PDE5A encodes a phosphodiesterase that degrades cyclic GMP, with downstream effects on smooth muscle tone and metabolic tissue biology that may affect fat distribution through vascular and cellular signaling pathways.
What the research says
Justice et al. (2019) applied whole-exome sequencing to large population cohorts to identify protein-coding variants contributing to body fat distribution. The study identified genes not previously linked to WHR through common-variant approaches, including novel findings at lipid homeostasis loci such as ANGPTL4 and ACVR1C. Using the additive model framework provided well-calibrated effect estimates and enabled discovery of variants whose effects accumulate linearly across allele copies.
The value of focusing on protein-coding variants—changes within gene exons that alter the amino acid sequence of a protein—is that they provide more direct functional hypotheses than regulatory variants near genes. When a protein-coding variant in ACVR1C associates with central adiposity, it points to that protein's function as the likely mechanism, rather than requiring inference about which nearby gene a regulatory variant might influence.
Additive-model WHR loci span lipid trafficking (ANGPTL4), fat depot developmental identity (TBX15), TGF-beta signaling (ACVR1C), and lipolysis regulation (RAPGEF3), reflecting multiple convergent pathways in central fat accumulation genetics (Justice et al., 2019).
The additive model assumption holds well for WHR because the trait's genetic architecture is highly polygenic—many variants each contributing small effects that sum across the genome. Under these conditions, the additive model captures the bulk of common-variant heritability and provides accurate effect size estimates useful for downstream analyses including polygenic scoring and functional follow-up.
How fat distribution affects you
Elevated waist-to-hip ratio is associated with greater susceptibility to cardiometabolic conditions, elevated fasting triglycerides, and increased visceral fat accumulation. The lipid biology signals in this gene set—particularly ANGPTL4—connect WHR genetics directly to lipolysis regulation and fatty acid trafficking. Individuals with variants affecting ANGPTL4 function may have altered rates of fatty acid release from or uptake into specific fat depots, contributing over time to where fat preferentially accumulates.
The TBX15 signal speaks to a different dimension: developmental programming. The positional identity of fat cells—whether they take on abdominal or gluteal characteristics—appears partly set during development by transcription factors like TBX15. This suggests that central adiposity susceptibility is not only a matter of ongoing metabolic regulation but also of the foundational cellular identity established in fat depots during development.
Working with your profile
Exercise type influences lipolysis rates and fat distribution patterns. Endurance exercise upregulates LPL activity in muscle and promotes fat oxidation from circulating lipoproteins. Interval and resistance training shift substrate utilization and can reduce central adiposity over longer periods. For individuals with variants affecting lipase regulation, exercise responses may differ in degree but the directional benefit of regular activity remains consistent with population-level evidence.
Dietary fat composition and carbohydrate intake both influence fatty acid partitioning and lipoprotein lipase activity. Diets lower in refined carbohydrates are consistently associated with more favorable fat distribution patterns in controlled studies, likely through insulin-mediated effects on lipolysis and fatty acid uptake. Monitoring waist-to-hip ratio alongside body weight gives a more complete picture of whether compositional changes are occurring even when total weight is stable.
This content is provided for educational purposes only.
Related traits and genes
WHR genetics from the additive model overlaps with other body composition phenotypes. FGFR4 and RSPO3 are recurring signals across multiple body composition studies. ANGPTL4 also appears in studies of HDL cholesterol and triglycerides, reflecting its broad role in lipid metabolism. TBX15 is relatively selective to fat distribution versus total adiposity, suggesting a specific role in depot identity rather than overall fat mass regulation. ACVR1C signals appear in both fat distribution and metabolic trait analyses, consistent with its role in hepatic and adipose TGF-beta signaling.